Source: ReachBio Youtube Channel

ReachBio posted a video "Assessing Off Target Toxicity & Linker Stability for ADC Therapeutics" on YOUTUBE

See Video »

ReachBio's Competitors | ReachBio's News | ReachBio's Financials

Followers on Owler

168

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Co-Founder

Emer Clarke

CEO Approval Rating

82/100

ReachBio is a Washington-based CRO that offers services such as antiviral testing and target validation for drug development and life science applications.